Loading clinical trials...
Loading clinical trials...
An Open Label Pilot Study of Purified (-)-Epicatechin to Improve Hemodynamics in Pulmonary Arterial Hypertension
Conditions
Interventions
(-)-Epicatechin
Locations
1
United States
UCSF
San Francisco, California, United States
Start Date
July 1, 2013
Primary Completion Date
January 1, 2014
Completion Date
January 1, 2014
Last Updated
September 10, 2014
NCT06649110
NCT07218029
NCT06481852
NCT01347216
NCT05464095
NCT06954727
Lead Sponsor
University of California, San Francisco
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions